| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Compass Therapeutics, Inc. | Chief Accounting Officer | Common Stock | 382,500 | $1,977,525 | $5.17 | 02 Jan 2026 | Direct |
| Compass Therapeutics, Inc. | Chief Accounting Officer | Stock Option (Right to Buy) | 435,000 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | 02 Jan 2026 | 2 | +$323,125 | 4 | Chief Accounting Officer | 05 Jan 2026, 16:32 |
| CMPX | Compass Therapeutics, Inc. | 07 Apr 2025 | 1 | +$28,400 | 4 | CHIEF ACCOUNTING OFFICER | 08 Apr 2025, 09:25 |
| CMPX | Compass Therapeutics, Inc. | 11 Feb 2025 | 1 | $0 | 4 | SVP, CAO | 13 Feb 2025, 17:11 |
| CMPX | Compass Therapeutics, Inc. | 09 Dec 2024 | 0 | $0 | 3 | VP Finance | 10 Dec 2024, 14:00 |